Clinical Trial

Comprehensive Enhanced Care Management Under CalAIM for High-Risk Medi-Cal Members

Study acronym: COMPASS-CalAIM
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This pragmatic, cluster-randomized trial will evaluate whether a comprehensive CalAIM-aligned care model consisting of Enhanced Care Management, selected Community Supports, Transitional Care Services, and residential care coordination improves population health outcomes among high-risk Medi-Cal managed care members in California compared with usual CalAIM service delivery. The intervention is intended to improve continuity of care after discharge, reduce potentially avoidable utilization, increase successful linkage to outpatient and social supports, and improve community tenure and patient-reported outcomes.
Trial Details
NCT Number NCT07587073
Lead Sponsor StratiHealth
Conditions Complex Care, Post-Acute Care Utilization, Housing Instability, Residential Care Transition, Population Health Management, Care Transitions
Enrollment 1,200 participants
Start Date 2026-10-01
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-14